208 related articles for article (PubMed ID: 30783324)
1. Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study.
Thomson SR; Chogtu B; Shetty R; Devasia T
Indian J Pharmacol; 2018; 50(6):320-325. PubMed ID: 30783324
[TBL] [Abstract][Full Text] [Related]
2. The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.
Kim TM; Kim H; Jeong YJ; Baik SJ; Yang SJ; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1156-1163. PubMed ID: 28556206
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of glycemic status among hypercholesterolemic patients on atorvastatin in a tertiary care hospital - A retrospective study.
Nalini R; Ramya JE; Karthick R
Indian J Pharmacol; 2022; 54(3):165-170. PubMed ID: 35848686
[TBL] [Abstract][Full Text] [Related]
4. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
5. Risk of new-onset diabetes mellitus during treatment with low-dose statins in Japan: A retrospective cohort study.
Kato S; Miura M
J Clin Pharm Ther; 2018 Aug; 43(4):536-542. PubMed ID: 29484697
[TBL] [Abstract][Full Text] [Related]
6. New onset diabetes mellitus induced by statins: current evidence.
Chrysant SG
Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
[TBL] [Abstract][Full Text] [Related]
7. Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.
Kamran H; Kupferstein E; Sharma N; Karam JG; Myers AK; Youssef I; Sowers JR; Gustafson DR; Salifu MO; McFarlane SI
Cardiorenal Med; 2018; 8(2):105-112. PubMed ID: 29617000
[TBL] [Abstract][Full Text] [Related]
8. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.
Trias F; Pintó X; Corbella E; Suárez-Tembra M; Ruíz-García A; Díaz-Díaz JL; Sánchez-Ruíz-Granado E; Sarasa I; Martínez-Porqueras R; Rodríguez-Sánchez MA; Corbella X;
Med Clin (Barc); 2022 Jun; 158(11):531-539. PubMed ID: 34517987
[TBL] [Abstract][Full Text] [Related]
9. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
10. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy.
Wang KL; Liu CJ; Chao TF; Chen SJ; Wu CH; Huang CM; Chang CC; Wang KF; Chen TJ; Lin SJ; Chiang CE
Am J Cardiol; 2014 Feb; 113(4):631-6. PubMed ID: 24360773
[TBL] [Abstract][Full Text] [Related]
11. Statins Are Associated With Increased Insulin Resistance and Secretion.
Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
[TBL] [Abstract][Full Text] [Related]
12. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
15. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
16. Statin-induced new onset of diabetes in dyslipidemic patients: a retrospective study.
Roy R; Ajithan A; Joseph A; Mateti UV; K S
Postgrad Med; 2019 Aug; 131(6):383-387. PubMed ID: 31311373
[No Abstract] [Full Text] [Related]
17. Associations of statin use with glycaemic traits and incident type 2 diabetes.
Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH
Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy with or without ezetimibe and the progression to diabetes.
Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC
J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961
[TBL] [Abstract][Full Text] [Related]
19. Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.
González-Lleó AM; Sánchez-Hernández RM; Plana N; Ibarretxe D; Rehues P; Ribalta J; Llop D; Wägner AM; Masana L; Boronat M
Cardiovasc Diabetol; 2024 Jan; 23(1):4. PubMed ID: 38172901
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
